Previous work has demonstrated that in vivo hepatic macrophage complement receptor clearance function is depressed after thermal injury. To determine whether impairment of complement receptor function is important in host defense, the present study evaluated the effect of the depression of complement receptor function in uninjured animals on susceptibility to endotoxin shock and bacterial infection. Hepatic complement receptor clearance function was evaluated by measuring the hepatic uptake of a test dose (2.9 x 108/100 g) of rat erythrocytes coated with anti-erythrocyte immunoglobulin M (EIgM) or EIgG in rats. Depression of hepatic complement receptor function was induced by the injection of EIgG. The hepatic uptake of the test dose of
Hepatic macrophages have complement receptors on their surface. The function of these receptors is considered to be the clearance of complement-coated bacteria and yeasts as well as large immune complexes from the blood (19) . A recent study from this laboratory has demonstrated that there is a depression of hepatic macrophage complement receptor clearance function after experimental thermal injury (5) . Since thermal injury is associated with an increase in susceptibility to infection (1, 17) , it was speculated that a depression in complement receptor function may contribute to the impairment of host defense.
The present study used erythrocytes coated with antierythrocyte immunoglobulin M (EIgM) and EIgG to determine hepatic macrophage complement receptor clearance function. Complement receptor function was depressed in uninjured animals by the injection of EIgG. The effect of the depression of complement receptor clearance function in this manner on the mortality rate after the injection of endotoxin or Pseudomonas aeruginosa was determined.
MATERIALS AND METHODS
Preparation of EIgM and EIgG. Inbred, male, SpragueDawley rats (weight, 200 to 250 g) were used for all experiments. Blood was collected in acid citrate-glucose solution, and the erythrocytes were washed three times in phosphatebuffered saline (PBS) (0.9% NaCl and 5 mM phosphate buffer [pH 7.4] ). Erythrocytes were treated with IgM or IgG fractions of rabbit anti-rat erythrocyte antisera. Antisera were obtained from U.S. Biochemical Corp. or from immunized New Zealand white rabbits. These rabbits had received six injections of 2.5 x 1010 erythrocytes (half of each injection was given intraperitoneally and half was given intravenously [i.v.]) over 2 weeks.
Antisera were collected 5 days after the last injection, and the 40% ammonium sulfate precipitate was separated into IgM and IgG fractions by gel filtration (Sephacryl 400) * Corresponding author.
chromatography. Fractionation was verified by immunodiffusion against appropriate antibodies, and the small amount of IgG present in the IgM fraction was removed with protein A. For treatment with IgM or IgG, packed erythrocytes were diluted to a concentration of 2 x 109/ml in PBS containing 1% gelatin. The antibody was diluted in a volume of PBS-gelatin equal to the volume of the erythrocyte suspension and added over 3 min to the erythrocytes with constant stirring. The mixture was incubated at 37°C for 30 min, and the EIgM or EIgG were washed twice in PBS. The concentration of antibody used for treatment was adjusted to obtain a 65 to 80% hepatic localization of the dose of 2.9 x 108 EIgM or EIgC per 100 g at 10 min after injection. All antibody-treated erythrocytes were used on the day of preparation.
Clearance of EIgM and EIgG from the blood. EIgM and EIgG used for clearance studies were labeled with 51Cr before treatment with antibodies. Animals were anesthetized with ether or sodium pentobarbital (30 mg/kg i.v.) before giving injections and taking blood samples. Erythrocytes, EIgM, or EIgG were injected i.v. at a dose of 2.9 x 108/100 g. Blood radioactivity was monitored over 2 h, and localization in the liver and spleen was determined at 10, 30, and 120 min after injection. Organ localization data were not corrected for the blood present in the organs, and blood volume was assumed to be 6% body weight. To verify the complement dependence of the clearance of EIgM and EIgG, cobra venom factor (CVF) was injected intraperitoneally (20 U/100 g) 18 h before the clearance determination. Determination of hepatic blood flow. Since the liver is the principal organ for the clearance of EIgM and EIgG, a sufficient decrease in hepatic blood flow could decrease the clearance of these test particles (18) . Hepatic blood flow was measured by the fractional clearance technique (7). Gelatinized lipid emulsion was used as the test particle and was injected at a dose of 5.0 mg/100 g. At this dose, the rate-limiting factor in the clearance of this test particle is hepatic blood flow and not hepatic phagocytic function (20) . Blood samples were taken every 30 s for 3 min from a cannulated carotid artery in anesthetized animals. The clearance rate constant, which is the proportion of the blood volume cleared of the test particle per minute, was multiplied by the blood volume to give the hepatic blood flow. Blood volume was estimated by extrapolating the clearance RESULTS Hepatic complement receptor clearance function was assessed from the hepatic uptake of a test dose (2.9 x 108/100 g) of labeled EIgM or EIgG. Both EIgM and EIgG were removed rapidly from the blood over the first 5 to 10 min after injection (Fig. 1 ). Blood levels of EIgM subsequently increased, whereas the blood levels of EIgG remained low. Hepatic localization of EIgM and EIgG reflected the blood levels over this time period with hepatic localization of EIgM rising and then falling, whereas hepatic localization of EIgG remained high (Fig. 2) Before the studies on the effect of injecting EIgG on hepatic complement receptor clearance function, the clearance characteristics of different doses of EIgG were determined. Blood levels of EIgG tended to decrease more slowly as the dose was increased (Fig. 3) . The number of EIgG in the liver and spleen at 30 min after injection increased as the dose was increased ( Table 1 ). The hepatic localization of erythrocytes increased as the dose was increased, and this represented a constant 3 to 4% of the ID.
Hepatic complement receptor clearance function was determined beginning 30 min after the injection of unlabeled EIgG at a dose of (per 100 g) 2.9 x 108, 8.7 x 108, or 17.4 x 108. The smallest dose of EIgG had no effect, whereas the two larger doses depressed the hepatic uptake of the test dose of EIgM and EIgG (Fig. 4) was probably due to the low lytic activity of complement for homologous erythrocytes (13 In a previous study, we demonstrated that thermal injury in rats was associated with the hepatic uptake of 1.71% of the unlysed erythrocyte mass (10) . This represents a hepatic uptake of 15 x 108 erythrocytes, which is more than the number of EIgG required to depress receptor function and increase susceptibility to endotoxin shock and bacterial infection (Table 1) . Therefore, it may be concluded that the hemolysis associated with thermal injury is sufficient tdepress hepatic macrophage receptor function and host defense.
The mechanism of the increased susceptibility to endotoxin shock and bacterial injection remains to be determined. The depression of complement receptor clearance function suggests the possibility of depressed clearance of (10, 22) . It was shown that splenic uptake of ca. 20
x 108 heat-damaged or phenylhydrazine-treated erythrocytes was required to increase susceptibility to endotoxin shock or septic peritonitis. In the present study, splenic uptake of EIgG was less than half this number (Table 1) . Therefore, splenic uptake of EIgG could have contributed to the depression of host defense caused by EIgG but could not. by itself, account for this finding. The increased susceptibility to endotoxin shock caused by EIgG was not due to a depletion of complement, because it has been shown that depletion of more than 90% of complement activity with CVF does not affect the susceptibility of rats to endotoxin shock (15) . Whatever the mechanism of the depressed host defense caused by EIgG, this study suggests that monitoring complement receptor clearance function may provide information on host defense status. This is a realistic proposal because antibody-coated erythrocytes have been used in patients to evaluate macrophage receptor function (8, 14) . IgM-coated erythrocytes may be the best test particle for this purpose, because fewer of these erythrocytes are phagocytized than erythrocytes coated with IgG (9).
